334 Phase II study evaluating a chemokine-modulatory (CKM) regimen in patients with colorectal cancer (CRC) metastatic to the liver

• Pawel Kalinski,
• Patrick Boland,
• Kristopher Attwood,
• Melissa Grimm,
• Sarbajit Mukherjee,
• Medhavi Gupta

Affiliations

Pawel Kalinski

1Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Patrick Boland

2Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA

Kristopher Attwood

1Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Melissa Grimm

1Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Sarbajit Mukherjee

1Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Medhavi Gupta

1Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA